NCT00613626 Cisplatin + Etoposide +/- Concurrent ZD6474 in Previously Untreated Extensive Stage Small Cell Lung Cancer Status COMPLETED Phase PHASE2
NCT00608205 Radiation Therapy Cisplatin With or Without Fluorouracil Patients With Stage III or Stage IV Head and Neck Cancer Status COMPLETED Phase PHASE3
NCT00603408 Effect of Chemotherapy and Radiation Prior to Surgery for Triple Negative Breast Cancer Status TERMINATED Phase PHASE2
NCT00602082 Capecitabine and Streptozocin With or Without Cisplatin in Treating Patients With Unresectable or Metastatic Neuroendocrine Tumors Status COMPLETED Phase PHASE2
NCT00601705 Epirubicin, Oxaliplatin and Fluorouracil (EOF) in Cancer of the Esophagus, Gastroesophageal Junction, or Stomach Status COMPLETED Phase PHASE2
NCT00601692 Irinotecan, Radiation Therapy, and Docetaxel With or Without Cisplatin in Treating Patients With Locally Advanced Esophageal Cancer Status COMPLETED Phase PHASE1
NCT00601510 Imatinib, Capecitabine, and Cisplatin in Treating Patients With Unresectable or Metastatic Stomach Cancer Status COMPLETED Phase PHASE1
NCT00599131 Cetuximab and Radiation Therapy in Laryngeal Cancer Patients Who Have Responded to One Cycle of Chemotherapy (SPORE) Status TERMINATED Phase PHASE2
NCT00592501 Proton Radiotherapy With Chemotherapy for Nasopharyngeal Carcinoma Status COMPLETED Phase PHASE2
NCT00590967 A Phase II Study of Extended Field IMRT External Beam Irradiation and Intracavitary Brachytherapy Status TERMINATED Phase PHASE2
NCT00590031 Phase II Trial of Preoperative Combined Modality Therapy for Esophageal Carcinoma: Cisplatin-Irinotecan Followed by Radiation Therapy With Concurrent Cisplatin and Irinotecan. Status COMPLETED Phase PHASE2
NCT00589056 Nelfinavir, Radiation Therapy, Cisplatin, and Etoposide in Treating Patients With Stage III Non-Small Cell Lung Cancer That Cannot Be Removed By Surgery Status COMPLETED Phase PHASE1/PHASE2
NCT00588770 Chemotherapy With or Without Bevacizumab in Treating Patients With Recurrent or Metastatic Head and Neck Squamous Cell Carcinoma Status ACTIVE_NOT_RECRUITING Phase PHASE3
NCT00586846 Phase II Study of Chemotherapy and Pamidronate for the Treatment of Newly Diagnosed Osteosarcoma Status COMPLETED Phase PHASE2
NCT00583674 Phase 2 Study of AMG 386 (20060439) in Combination With Cisplatin & Capecitabine in Subjects With Metastatic Gastric, Gastroesophageal Junction, or Distal Esophageal Adenocarcinoma Status COMPLETED Phase PHASE2
NCT00580983 Optimized Intensity Modulated Irradiation for Head and Neck Cancer Status COMPLETED Phase NA
NCT00580333 Preoperative Cisplatin and Bevacizumab in ER-, PR-, HER2 Negative Breast Cancer Status COMPLETED Phase PHASE2
NCT00578864 Protracted Etoposide During Induction Therapy for High Risk Neuroblastoma Status COMPLETED Phase PHASE2
NCT00577993 Fludarabine, Mitoxantrone, and Dexamethasone (FND) Plus Rituximab for Lymphoma Patients Status COMPLETED Phase PHASE3
NCT00577707 Erlotinib and Chemotherapy for Patients With Stage IB-IIIA NSCLC With EGFR Mutations (ECON) Status COMPLETED Phase PHASE2